Oct 27, 2010 00:30 EDT DuoCort Pharma announces it has concluded an agreement with Recipharm under which Recipharm is set to scale-up the manufacturing of DuoCort’s tablets to commercial scale as DuoCort Pharma prepares for market entry with its orphan drug for the treatment of Addison’s disease.
Image
Carl-Johan Spak, Executive Vice President, Recipharm
Oct 27, 2010 00:20 EDT
Size:3.34 MB
Format:tif
Image dimensions:2835 x 4252 pixels
